2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis (original) (raw)

• Fiegelson HS, Henderson BE (1996) Estrogens and breast cancer (review). Carcinogenesis 17:2279–2284
  Article Google Scholar
• McDonald TW, Annegers JF, O’Fallon WM, Dockerty MB, Malkasian GD Jr, Kurland LT (1977) Exogenous estrogen and endometrial carcinoma: case-control and incidence study. Am J Obstet Gynecol 127:572–580
  PubMed CAS Google Scholar
• Pritchard KI (2000) Current and future directions in medical therapy for breast carcinoma: endocrine treatment. Cancer 88(Suppl 12):3065–3072
  Article PubMed CAS Google Scholar
• Seegers JC, Aveling ML, Van Aswegen CH, Cross M, Koch F, Joubert WS (1989) The cytotoxic effects of estradiol-17-beta, catecholestradiol and methoxyestradiol on dividing MCF-7 and HeLa cells. J Steroid Biochem 32:797–809
  Article PubMed CAS Google Scholar
• Berg D, Sonsalla R, Kuss E (1983) Concentrations of 2-methoxyestrogens in human serum measured by a heterogenous immunoassay with an 125I-labelled ligand. Acta Endrocinol (Copenh) 103:1375–1378
  Google Scholar
• Klauber N, Parangi S, Flynn E, Hammel E, D’Amato RJ (1997) Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57:81–86
  PubMed CAS Google Scholar
• Kataoka M, Schumacher G, Cristiano RJ, Atkinson EN, Roth JA, Mukhopadhyay T (1998) An agent that increases tumor suppressor transgene product coupled with systemic transgene delivery inhibits growth of metastatic lung cancer in vivo. Cancer Res 58:4761–4765
  PubMed CAS Google Scholar
• Schumacher G, Kataoka M, Roth JA, Mukhopadhyay T (1999) Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines. Clin Cancer Res 5:493–499
  PubMed CAS Google Scholar
• Wassberg E (1999) Angiostatic treatment of neuroblastoma. Ups J Med Sci 104:1–24
  Article PubMed CAS Google Scholar
• Lin HL, Liu TY, Chau GY, Lui WY, Chi CW (2000) Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer 89:983–994
  Article PubMed CAS Google Scholar
• Bu S, Blaukat A, Fu X, Heldin NE, Landstrom M (2002) Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS Lett 531:141–151
  Article PubMed CAS Google Scholar
• LaValle TM, Zhan XH, Herbstritt CJ, Kough KC, Green SJ, Pribluda VS (2002) 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors a and b. Cancer Res 62:3691–3697
  Google Scholar
• Fostis T, Zhang Y, Pepper MS, Alder cruetz H, Montesano R, Nawroth PP, Schweigerer L (1994) The endogenous estrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppress tumor growth. Nature 368:237–239
  Article Google Scholar
• Cushman M, He HM, Katzenellenbogen JA, Lin CM, Hamel E (1995) Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicines binding site. J Med Chem 38:2041–2049
  Article PubMed CAS Google Scholar
• Attalla H, Makels TP, Adelkreutz H, Anderson LC (1996) 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochem Biophys Res Comm 228:467–473
  Article PubMed CAS Google Scholar
• Gao N, Rahmani M, Dent P, Grant S (2005) 2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen apecies and Akt-dependent process. Oncogene 14:3797–3809
  Article CAS Google Scholar
• McCormick DL, Johmson WD, Peibluda VS, Green SJ, Tomaszewski JE, Smith AC (2000) Preclinical development of 2-methoxyestradiol (2ME2, NSC-659853) (abstract). Proc Am Assoc Cancer Res 41(2080):328
  Google Scholar
• Schumacher G, Scheunert S, Rueggeberg A, Bachem MG, Nussler AK, Spinelli A, Mukhopadhyay T, Pratchke J, Neuhaus P (2006) A very low toxic agent induces apoptosis and reduces growth of human hepatocellular carcinoma cells. Hepatology 21:1207–1212
  CAS Google Scholar
• Nilsson I, Hoffman I (2000) Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res 4:107–144
  PubMed CAS Google Scholar
• Jinno S, Suto J, Nagata A, Igarashi M, Kanaoka Y, Nojima H, Okayama H (1994) Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J 13:1549–1556
  PubMed CAS Google Scholar
• Forrest AR, McCormack AK, DeSouza CP, Sinnamon JM, Tonks ID, Haywrd NK, Ellem K, Gabrielli BG (1999) Multiple splicing variants of cdc25B regulate G2/M progression. Biochem Biophys Res Commun 260:510–515
  Article PubMed CAS Google Scholar
• Donazelli M, Draetta GF (2003) Regulating mammalian checkpoints through Cdc25 inactivation. EMBO J 4:671–677
  Article CAS Google Scholar
• Molinari M, Mercurilo C, Dominguez J, Goubin F, Draetta GF (2000) Human Cdca5A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO J 1:71–79
  Article CAS Google Scholar
• Mailand N, Falck J, Lukas C, Syljuasen RG, Welcker M, Lukas J (2000) Rapid destruction of human Cdc25A in response to DNA damage. Science 288:1425–1429
  Article PubMed CAS Google Scholar
• Santamaria D, Barriere C, Cerqueira A, Hunt S, Tardy c, Newton K, Caceres JF, Dubus P, Malumbres M, Barbacid M (2007) Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448:811–816
  Article PubMed CAS Google Scholar
• Parsons AR (1998) Phosphatases and tumorigenesis. Curr Opin Oncol 10:88–91
  Article PubMed CAS Google Scholar
• Kristjansdottir K, Rudolph J (2004) Cdc25 phosphatases and cancer. Chem Biol 11:1043–1051
  Article PubMed CAS Google Scholar
• Gasparotto D, Maestro R, Piccinin S, Vukosavljevic T, Barzan L, Sulfaro S, Boiocchi M (1997) Overexpression of Cdc25A and Cdc25B in head and neck cancers. Cancer Res 57:2366–236
  PubMed CAS Google Scholar
• Hernandez S, Besser X, Bea S et al (2001) Differential expression of Cdc25 cell-cycle activating phosphatases in human colorectal carcinoma. Lab Invest 81:465–470
  PubMed CAS Google Scholar
• Carr BI, Wang Z, Wang M, Kar S, Wilcox CS, Rosi K, Southwick E, Lazo JS (2003) A Cdc25A antagonizing K vitamin inhibits hepatocyte DNA synthesis in vitro and in vivo. J Mol Biol 326:721–735
  Article PubMed CAS Google Scholar
• Kar S, Wang M, Ham SW, Carr BI (2006) H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERK. Cancer Biol Ther 5:1340–1347
  Article PubMed CAS Google Scholar
• Nishikawa Y, Carr BI, Wang Z, Kar S, Finn F, Dowd P, Zheng ZB, Kerns J, Naganathan SJ (1995) Growth inhibition of hepatoma cells induced by vitamin K and its analogs. J Biol Chem 270:28304–28310
  Article PubMed CAS Google Scholar
• Kar S, Carr BI (2000) Growth inhibition and protein tyrosine phosphorylation in MCF7 breast cancer cells by a novel K-vitamin. J Cell Physiol 185:386–393
  Article PubMed CAS Google Scholar
• Tamura K, Southwick EC, Kerns J, Rosi K, Carr BI, Wilcox C, Lazo J (2000) Cdc25 inhibition and cell cycle arrest by a synthetic thioalkyl vitamin K analogue. Cancer Res 60:1317–1325
  PubMed CAS Google Scholar
• Novicki DL, Jirtle RL, Michalopoulos G (1983) Establishment of two rat hepatoma cell strains produced by a carcinogen initiation, phenobarbital promotion protocol. In Vitro 19:191–202
  Article PubMed CAS Google Scholar
• D’Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E (1994) 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91:3964–3968
  Article PubMed CAS Google Scholar
• Kar S, Lefterov IM, Wang M, Lazo JS, Scott CN, Wilcox CS, Carr BI (2003) Binding and Inhibition of Cdc25 phosphatases by vitamin K analogues. Biochemistry 42:10490–10497
  Article PubMed CAS Google Scholar
• Kar S, Wang M, Ham SW, Carr BI (2006) Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK. Biochem Pharmacol 72:1217–1227
  Article PubMed CAS Google Scholar
• Huber JB et al (2000) Oral administration of an estrogen metabolite-induced potentiation of radiation anti-tumor effects in presence of wild type p53 in non small cell lung cancer. Int J Radiat Oncol Biol Phys 48:1127–1137
  Article Google Scholar
• Sweeney C et al (2005) A phase II multicenter, randomised, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer. Clin Cancer Res 11:6625–6633
  Article PubMed CAS Google Scholar
• Dahut WL et al (2006) Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors. Cancer Biol Ther 5:22–27
  Article PubMed CAS Google Scholar
• Lakhani NJ et al (2005) Determination of 2-methoxyestradiol in human plasma, using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 19:1176–1182
  Article PubMed CAS Google Scholar
• Ireson CR et al (2004) Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. Br J Cancer 90:932–937
  Article PubMed CAS Google Scholar
• Chen RA, Michaeli T, Van Aelst L, Ballester R (2000) A role of the noncatalytic N terminus in the function of Cdc25, a Saccharomyces cerevisiae Ras-Guanine nucleotide exchange factor. Genetics 154:1473–1484
  PubMed CAS Google Scholar
• Fernandes-Alnemri T et al (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.J Biol Chem 269:30761–30764
  PubMed CAS Google Scholar
• Nicholson DW, Thornberry NA, Vaillancourt JP, Ding CK et al (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37–43
  Article PubMed CAS Google Scholar
• Kar S, Wang M, Wilcox CS, Carr BI (2003) Antitumor and anticarcinogenic action of Cpd 5: a new class of protein phosphatase inhibitor. Carcinogenesis 24:411–416
  Article PubMed CAS Google Scholar